# An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

> **NCT02229903** · NA · COMPLETED · sponsor: **Brainsway** · enrollment: 100 (actual)

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DEVICE:** Active DTMS Treatment
- **DEVICE:** Sham Treatment

## Key facts

- **NCT ID:** NCT02229903
- **Lead sponsor:** Brainsway
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229903, "An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02229903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*